Dosar de subiect

India's Affordable Weight-Loss Drugs May Impact Global Obesity

Primul articol: 18 mar. 2026, 02:30 | Ultima actualizare: 18 mar. 2026, 02:30 | 1 sursa | 1 articol

Mai multe surse. Mai putina manipulare.

Analiza editoriala

Bazat pe 1 sursa, 1 articol

The availability of inexpensive weight-loss medications from India offers a new approach to tackling the global obesity crisis. These drugs, produced at a fraction of the cost compared to those in Western markets, could make treatment accessible to a larger population, particularly in low- and middle-income countries where obesity rates are rising. This shift could lead to a re-evaluation of obesity treatment strategies, focusing on affordability and widespread availability.

Articole despre acest subiect

India's cheap weight-loss drugs could reshape global obesity fight Foto: BBC UK
BBC UK English 18 mar. 2026, 02:30 (acum 6 ore)

India's cheap weight-loss drugs could reshape global obesity fight

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Citeste pe BBC UK →